抗微生物ペプチド
参照文献

↑  Devine & Bibby 1994
1 2   Kōkin pepuchido no kinō kaimei to gijutsu riyō. Nagaoka, Isao., 長岡功.. Tōkyō: Shīemushīshuppan. (2017). ISBN 9784781312453. OCLC 987660277. https://www.worldcat.org/oclc/987660277
1 2  Yeaman & Yount 2003
↑  Papagianni 2003
↑  Sitaram & Nagaraj 2002
↑  Dürr, Sudheendra & Ramamoorthy 2006
↑  Dhople, Krukemeyer & Ramamoorthy 2006
↑  Hancock & Rozek 2002
1 2 3  Brogden 2005
↑  Daniel J Hirst, Tzong-Hsien Lee, Marcus J Swann, Sharon Unabia, Yoonkyung Park, Kyung-Soo Hahm and Marie Isabel Aguilar, The effect of acyl chain structure and bilayer phase state on the binding and insertion of HPA3 onto a supported lipid bilayer, European Biophysics Journal
↑  Tzong-Hsien Lee, Christine Heng, Marcus J. Swann, John D. Gehman, Frances Separovic, Marie-Isabel Aguilar, Real time quantitative analysis of lipid disordering by aurein 1.2 during membrane adsorption, destabilisation and lysis, . Biochimica et Biophysica Acta (BBA) - Biomembranes, Volume 1798, Issue 10, October 2010, Pages 1977-1986.
↑  Amsterdam 1996
↑  Hunter et al. 2002
↑  Hoskin & Ramamoorthy 2008
↑  Mátyus, Kandt & Tieleman 2007
↑  Langham, Ahmad & Kaznessis 2008
↑  Hallock, Lee & Ramamoorthy 2003
↑  Wildman, Lee & Ramamoorthy 2003
1 2  Matsuzaki 2008
↑  Kitagawa, Norio; Otani, Takahito; Inai, Tetsuichiro (2018-10-23). “Nisin, a food preservative produced by Lactococcus lactis, affects the localization pattern of intermediate filament protein in HaCaT cells”. Anatomical Science International. doi:10.1007/s12565-018-0462-x. ISSN 1447-073X. PMID 30353456. https://www.ncbi.nlm.nih.gov/pubmed/30353456.
↑  “[www.fsc.go.jp/fsciis/attachedFile/download?retrievalId=kai20080131sfc&fileId=109 食品安全委員会]”.   厚生労働省. 2018年12月20日閲覧。
1 2  Hancock & Sahl 2006
1 2  Zasloff 2002
1 2  Matsuzaki et al. 1995
↑  
Chou et al. 2008
↑  Tennessen 2005
↑  Lanlan Yu, Lin Guo, Jeak Ling Ding, Bow Ho, Si-Shen Feng, Jonathan Popplewell, Marcus Swann, Thorsten Wohland. Interaction of an artificial antimicrobial peptide with lipid membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes, Volume 1788, Issue 2, February 2009, Pages 333-344, Available online 25 October 2008
↑  Tzong-Hsien Lee, Kristopher Hall, Adam Mechler, Lisandra Martin, Jonathan Popplewell, Gerry Ronan, Marie-Isabel Aguilar Molecular Imaging and Orientational Changes of Antimicrobial Peptides in Membranes American Peptide Society (2007) Peptides for Youth. Eds. Emanuel Escher, William D. Lubell, Susan Del Valle
1 2  Peschel et al. 1999
↑  Campos et al. 2004
↑  China et al. 1994
↑  Nikaido 1996
↑  Whitelock et al. 1996
Amsterdam, D. (1996), “Susceptibility testing of Antimicrobials in liquid media”, in Lorian, V., Antibiotics in Laboratory Medicine (Fourth ed.), Baltimore, Md.: Williams and Wilkins, pp. 52–111
Brogden, K.A. (March 2005), “Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?”, Nature Reviews Microbiology 3 (3):  238–250., doi:10.1038/nrmicro1098, PMID 15703760
Campos, M.A.; Vargas, M.A.; Regueiro, V.; Llompart, C.M.; Alberti, S.; Bengoechea, J.A. (December 2004), Weiser, J.N., ed., “Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides”, Infection and Immunity 72 (12):  7107–7114, doi:10.1128/IAI.72.12.7107-7114.2004, PMC 529140, PMID 15557634, http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=529140 2009年4月27日閲覧。
China, B.; N'guyen, B.T.; De Bruyere, M.; Cornelis, G.R. (April 1994), “Role of YadA in resistance of Yersinia enterocolitica to phagocytosis by human polymorphonuclear leukocytes”, Infection and immunity 62 (4):  1275–1281, PMC 186269, PMID 8132334, http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=186269 2009年4月27日閲覧。
Chou, Hung-Ta; Kuo, Tsun-Yung; Chiang, Jung-Chun; Pei, Min-Ju; Yang, Wei-Ter; Yu, Hui-Chun; Lin, Shih-Bin; Chen, Wei-Jung (August 2008), “Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp”, International Journal of Antimicrobial Agents 32 (2):  130–138, doi:10.1016/j.ijantimicag.2008.04.003, PMID 18586467
Dhople, V.; Krukemeyer, A.; Ramamoorthy, A. (September 2006), “The human beta-defensin-3, an antibacterial peptide with multiple biological functions”, Biochimica et Biophysica Acta – Biomembranes 1758 (9):  1499–1512, doi:10.1016/j.bbamem.2006.07.007, PMID 16978580
Dürr, U.H.N.; Sudheendra, U.S.; Ramamoorthy, A. (September 2006), “LL-37, the only human member of the cathelicidin family of antimicrobial peptides”, Biochimica et Biophysica Acta – Biomembranes 1758 (9):  1408–1425, doi:10.1016/j.bbamem.2006.03.030, PMID 16716248
Giuliani, A.; Pirri, G.; Nicoletto, S. (March 2007), “Antimicrobial peptides: an overview of a promising class of therapeutics”, Cent. Eur. J. Biol. 2 (1):  1–33, doi:10.2478/s11535-007-0010-5
Hallock, K.J.; Lee, D.K.; Ramamoorthy, A. (May 2003), “MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain”, Biophys. J. 84 (5):  3052–3060, doi:10.1016/S0006-3495(03)70031-9, PMC 1302867, PMID 12719236, http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1302867
Hancock, Robert E.W.; Rozek, A. (2002), “Role of membranes in the activities of antimicrobial cationic peptides.”, FEMS Microbiology Letters 206 (2):  143–149, doi:10.1111/j.1574-6968.2002.tb11000.x, PMID 11814654
Hancock, Robert E.W.; Sahl, Hans-Georg (2006), “Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies”, Nature Biotechnology 24 (12):  1551–1557, doi:10.1038/nbt1267, PMID 17160061
Hoskin, D.W.; Ramamoorthy, A. (February 2008), “Studies on anticancer activities of antimicrobial peptides”, Biochimica et Biophysica Acta – Biomembranes 1778 (2):  357–375, doi:10.1016/j.bbamem.2007.11.008, PMC 2238813, PMID 18078805, http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2238813
Hunter, H.N.; Fulton, D.B.; Ganz, T.; Vogel, H.J. (October 2002), “The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.”, J Biol Chem 277 (40):  37597–37603, doi:10.1074/jbc.M205305200, PMID 12138110
Langham, Allison A.; Ahmad, Abdallah Sayyed; Kaznessis, Yiannis N. (April 2008), “On the Nature of Antimicrobial Activity: A Model for Protegrin-1 Pores”, J. Am. Chem. Soc. 130 (13):  4338–4346, doi:10.1021/ja0780380, PMC 2474802, PMID 18335931, http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2474802
Matsuzaki, Katsumi (2008), “Control of cell selectivity of antimicrobial peptides”, Biochimica et Biophysica Acta – Biomembranes 1788 (8):  1687–92, doi:10.1016/j.bbamem.2008.09.013, PMID 18952049
Matsuzaki, Katsumi; Ken-ichi, S.; Nobutaka, F.; Koichiro, M. (March 1995), “Molecular Basis for Membrane Selectivity of an Antimicrobial Peptides, Magainin 2”, Biochemistry 34 (10):  3423–3429, doi:10.1021/bi00010a034, PMID 7533538
Mátyus, Edit; Kandt, Christian; Tieleman, D Peter (2007), “Computer simulation of antimicrobial peptides”, Curr Med Chem 14 (26):  2789–98, doi:10.2174/092986707782360105, PMID 18045125
Moore, A.J.; Devine,, D.A.; Bibby,, M.C. (1994), “Preliminary experimental anticancer activity of cecropins”, Peptide Research 7 (5):  265–269, PMID 7849420
Nikaido, H. (October 1996), “Multidrug efflux pumps of gram-negative bacteria”, Journal of Bacteriology 178 (20):  5853–5859, PMC 178438, PMID 8830678, http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=178438 2009年4月27日閲覧。
Papagianni, M. (September 2003), “Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications”, Biotechnol Adv 21 (6):  465–499, doi:10.1016/S0734-9750(03)00077-6, PMID 14499150
Peschel, A.; Otto, M.; Jack, R.W.; Kalbacher, H.; Jung, G.; Götz, F. (March 1999), “Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides”, Journal of Biological Chemistry 274 (13):  8405–8410, doi:10.1074/jbc.274.13.8405, PMID 10085071
Sitaram, N.; Nagaraj, R. (2002), “Host-defense antimicrobial peptides: importance of structure for activity”, Curr Pharm Des 8 (9):  727–742, PMID 11945168
Tennessen, Jacob A. (November 2005), “Molecular evolution of animal antimicrobial peptide: widespread moderate positive selection”, Journal of Evolutionary Biology 18 (6):  1387–1394, doi:10.1111/j.1420-9101.2005.00925.x, PMID 16313451
Whitelock, J.M.; Murdoch, A.D.; Iozzo, R.V.; Underwood, P.A. (April 1996), “The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases”, Journal of Biological Chemistry 271 (17):  10079–10086, doi:10.1074/jbc.271.17.10079, PMID 8626565
Wildman, K.A.H.; Lee, D.K.; Ramamoorthy, A. (2003), “Mechanism of Lipid Bilayer Disruption by the Human Antimicrobial Peptide, LL-37”, Biochemistry 42 (21):  6545–6558, doi:10.1021/bi0273563, PMID 12767238
Yeaman, M.R.; Yount, N.Y. (March 2003), “Mechanisms of antimicrobial peptide action and resistance”, Pharmacological reviews 55 (1):  27–55, doi:10.1124/pr.55.1.2, PMID 12615953
Brogden, K.A. (March 2005), “Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?”, Nature Reviews Microbiology 3 (3):  238–250., doi:10.1038/nrmicro1098, PMID 15703760
Zasloff, Michael (January 2002), “Antimicrobial peptides of multicellular organisms”, Nature 415 (6870):  389–395, doi:10.1038/415389a, PMID 11807545
抗菌ペプチド3次元画像。様々な構造を持つのが特徴である。
The modes of action by Antimicrobial peptides
Molecular Basis of Cell Selectivity of Antimicrobial Peptides